Literature DB >> 3090153

Pulmonary infection in cystic fibrosis.

P A Friend.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090153     DOI: 10.1016/s0163-4453(86)92325-x

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  15 in total

Review 1.  The role of bacterial adhesion in cystic fibrosis including the staphylococcal aspect.

Authors:  R Ramphal
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

2.  Pseudomonas infections in cystic fibrosis.

Authors:  R H George
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

Review 3.  Host-parasite interaction in fungal infections.

Authors:  N Khardori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

4.  Mixed-morphotype broth microdilution susceptibility testing of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  K G Van Horn
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Serologic response to Candida albicans and Aspergillus fumigatus in cystic fibrosis.

Authors:  B Przyklenk; A Bauernfeind; G Hörl; G Emminger
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

6.  Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy.

Authors:  M Mulheran; C Degg; S Burr; D W Morgan; D E Stableforth
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  Ceftazidime treatment in cystic fibrosis: resistant organisms in sputum and faeces.

Authors:  A M Dalzell; D Sunderland; C A Hart; D P Heaf
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

8.  Serum antibodies to Aspergillus fumigatus catalase in patients with cystic fibrosis.

Authors:  H Schønheyder; T Jensen; I H Laessøe; N Høiby; C Koch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

9.  Differences in the binding specificities of Pseudomonas aeruginosa M35 and Escherichia coli C600 for lipid-linked oligosaccharides with lactose-related core regions.

Authors:  I J Rosenstein; C T Yuen; M S Stoll; T Feizi
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Stimulation by fibronectin of macrophage-mediated phagocytosis of Pseudomonas aeruginosa.

Authors:  J L Kluftinger; N M Kelly; R E Hancock
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.